Altimmune, Inc. — Director's Dealing 2020

Jun 30, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Altimmune, Inc. (ALT)
CIK: 0001326190
Period of Report: 2020-06-25

Reporting Person: Hodges Philip (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-06-25	Restricted Stock Units ("RSUs")	$	A	16850	Acquired		Common Stock (16850)	Direct

Footnotes

F1: Each RSU represents a contingent right to receive one share of Common Stock, par value $0.0001, when vested.

F2: The RSUs vest in full at the Company's 2020 annual meeting of stockholders, subject to the reporting person's continued service through the vesting date, and have no expiration date.